FDA Inspection 1309994 — Novum Pharmaceutical Research Services Inc.
The FDA completed an inspection of Novum Pharmaceutical Research Services Inc. on December 12, 2025 in Scarborough. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 12, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Scarborough (Canada)
Additional Details
Bioanalytical BA/BE